Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea

NCT05587387 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT05587387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05587387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2022
Completion date
July 27, 2023
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic neoplasms